653 related articles for article (PubMed ID: 11494364)
61. CAG repeat instability in embryonic stem cells and derivative spermatogenic cells of transgenic Huntington's disease monkey.
Khampang S; Parnpai R; Mahikul W; Easley CA; Cho IK; Chan AWS
J Assist Reprod Genet; 2021 May; 38(5):1215-1229. PubMed ID: 33611676
[TBL] [Abstract][Full Text] [Related]
62. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects.
Faideau M; Kim J; Cormier K; Gilmore R; Welch M; Auregan G; Dufour N; Guillermier M; Brouillet E; Hantraye P; Déglon N; Ferrante RJ; Bonvento G
Hum Mol Genet; 2010 Aug; 19(15):3053-67. PubMed ID: 20494921
[TBL] [Abstract][Full Text] [Related]
63. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
Kenney C; Powell S; Jankovic J
Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
[TBL] [Abstract][Full Text] [Related]
64. DRPLA transgenic mouse substrains carrying single copy of full-length mutant human DRPLA gene with variable sizes of expanded CAG repeats exhibit CAG repeat length- and age-dependent changes in behavioral abnormalities and gene expression profiles.
Suzuki K; Zhou J; Sato T; Takao K; Miyagawa T; Oyake M; Yamada M; Takahashi H; Takahashi Y; Goto J; Tsuji S
Neurobiol Dis; 2012 May; 46(2):336-50. PubMed ID: 22342974
[TBL] [Abstract][Full Text] [Related]
65. Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?
Kennedy L; Shelbourne PF
Hum Mol Genet; 2000 Oct; 9(17):2539-44. PubMed ID: 11030759
[TBL] [Abstract][Full Text] [Related]
66. Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes.
Dragileva E; Hendricks A; Teed A; Gillis T; Lopez ET; Friedberg EC; Kucherlapati R; Edelmann W; Lunetta KL; MacDonald ME; Wheeler VC
Neurobiol Dis; 2009 Jan; 33(1):37-47. PubMed ID: 18930147
[TBL] [Abstract][Full Text] [Related]
67. Progressive Polyglutamine Repeat Expansion in Peripheral Blood Cells and Sperm of Transgenic Huntington's Disease Monkeys.
Clever F; Cho IK; Yang J; Chan AWS
J Huntingtons Dis; 2019; 8(4):443-448. PubMed ID: 31561381
[TBL] [Abstract][Full Text] [Related]
68. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.
Hickey MA; Kosmalska A; Enayati J; Cohen R; Zeitlin S; Levine MS; Chesselet MF
Neuroscience; 2008 Nov; 157(1):280-95. PubMed ID: 18805465
[TBL] [Abstract][Full Text] [Related]
69. Lack of RAN-mediated toxicity in Huntington's disease knock-in mice.
Yang S; Yang H; Huang L; Chen L; Qin Z; Li S; Li XJ
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4411-4417. PubMed ID: 32029588
[TBL] [Abstract][Full Text] [Related]
70. Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease.
Moffitt H; McPhail GD; Woodman B; Hobbs C; Bates GP
PLoS One; 2009 Nov; 4(11):e8025. PubMed ID: 19956633
[TBL] [Abstract][Full Text] [Related]
71. Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.
Rué L; Bañez-Coronel M; Creus-Muncunill J; Giralt A; Alcalá-Vida R; Mentxaka G; Kagerbauer B; Zomeño-Abellán MT; Aranda Z; Venturi V; Pérez-Navarro E; Estivill X; Martí E
J Clin Invest; 2016 Nov; 126(11):4319-4330. PubMed ID: 27721240
[TBL] [Abstract][Full Text] [Related]
72. Expansion of a (CAG)n repeat region in a sporadic case of HD.
Bozza A; Malagù S; Calzolari E; Novelletto A; Pavoni M; del Senno L
Acta Neurol Scand; 1995 Aug; 92(2):132-4. PubMed ID: 7484060
[TBL] [Abstract][Full Text] [Related]
73. Regional differences of somatic CAG repeat instability do not account for selective neuronal vulnerability in a knock-in mouse model of SCA1.
Watase K; Venken KJ; Sun Y; Orr HT; Zoghbi HY
Hum Mol Genet; 2003 Nov; 12(21):2789-95. PubMed ID: 12952864
[TBL] [Abstract][Full Text] [Related]
74. Somatic CAG expansion in Huntington's disease is dependent on the MLH3 endonuclease domain, which can be excluded via splice redirection.
Roy JCL; Vitalo A; Andrew MA; Mota-Silva E; Kovalenko M; Burch Z; Nhu AM; Cohen PE; Grabczyk E; Wheeler VC; Mouro Pinto R
Nucleic Acids Res; 2021 Apr; 49(7):3907-3918. PubMed ID: 33751106
[TBL] [Abstract][Full Text] [Related]
75. Derivation of Huntington's disease-affected human embryonic stem cell lines.
Bradley CK; Scott HA; Chami O; Peura TT; Dumevska B; Schmidt U; Stojanov T
Stem Cells Dev; 2011 Mar; 20(3):495-502. PubMed ID: 20649476
[TBL] [Abstract][Full Text] [Related]
76. CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease.
Semaka A; Kay C; Doty C; Collins JA; Bijlsma EK; Richards F; Goldberg YP; Hayden MR
J Med Genet; 2013 Oct; 50(10):696-703. PubMed ID: 23896435
[TBL] [Abstract][Full Text] [Related]
77. Progressive CAG expansion in the brain of a novel R6/1-89Q mouse model of Huntington's disease with delayed phenotypic onset.
Vatsavayai SC; Dallérac GM; Milnerwood AJ; Cummings DM; Rezaie P; Murphy KP; Hirst MC
Brain Res Bull; 2007 Apr; 72(2-3):98-102. PubMed ID: 17352932
[TBL] [Abstract][Full Text] [Related]
78. High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington's disease CAG knock-in mice across multiple genetic backgrounds.
Ament SA; Pearl JR; Grindeland A; St Claire J; Earls JC; Kovalenko M; Gillis T; Mysore J; Gusella JF; Lee JM; Kwak S; Howland D; Lee MY; Baxter D; Scherler K; Wang K; Geman D; Carroll JB; MacDonald ME; Carlson G; Wheeler VC; Price ND; Hood LE
Hum Mol Genet; 2017 Mar; 26(5):913-922. PubMed ID: 28334820
[TBL] [Abstract][Full Text] [Related]
79. Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instability.
Williams LC; Hegde MR; Nagappan R; Faull RL; Giles J; Winship I; Snow K; Love DR
Genet Test; 2000; 4(1):55-60. PubMed ID: 10794362
[TBL] [Abstract][Full Text] [Related]
80. Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington's Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic Acid.
Vodicka P; Mo S; Tousley A; Green KM; Sapp E; Iuliano M; Sadri-Vakili G; Shaffer SA; Aronin N; DiFiglia M; Kegel-Gleason KB
J Huntingtons Dis; 2015; 4(2):187-201. PubMed ID: 26397899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
